Browsing Tag
Fas/FasL pathway
1 post
Scinai Immunotherapeutics secures Italian approval to advance Pincell acquisition and PC111 development
Scinai Immunotherapeutics receives Italian Golden Power clearance for proposed Pincell buyout, moving closer to advancing PC111 monoclonal antibody program.